相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy
Brandon C. Chapman et al.
DISEASES OF THE COLON & RECTUM (2023)
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?
Eric S. Christenson et al.
CURRENT ONCOLOGY REPORTS (2022)
Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI-H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study
Xuan Zhang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival
Haoyu Zhang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2022)
Targeting Akt-associated microRNAs for cancer therapeutics
Mir S. Adil et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data
Jia-Yi Li et al.
BMC CANCER (2021)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2021)
Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial
F. De Felice et al.
CLINICAL ONCOLOGY (2021)
Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies
Michal Jankowski et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Predictive value of serum and tissue carcinoembryonic antigens for radiologic response and oncologic outcome of rectal cancer
Chang Hyun Kim et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Rectal Cancer, Version 6.2020 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer
Chinock Cheong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial
Gianluca Masi et al.
EUROPEAN JOURNAL OF CANCER (2019)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial
Johan Erlandsson et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy
Ri Na Yoo et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)
Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial
Huabin Hu et al.
BMC CANCER (2018)
Total neoadjuvant therapy for rectal cancer: An emerging option
Ethan B. Ludmir et al.
CANCER (2017)
A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Yi Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Predictors of complete response and Disease recurrence Following chemoradiation for rectal cancer
Danielle S. Bitterman et al.
FRONTIERS IN ONCOLOGY (2015)
MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer
Regina G. H. Beets-Tan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Accuracy of Gadofosveset-enhanced MRI for Nodal Staging and Restaging in Rectal Cancer
Doenja M. J. Lambregts et al.
ANNALS OF SURGERY (2011)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn et al.
LANCET ONCOLOGY (2011)
Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases
Sang Joon Shin et al.
RADIATION ONCOLOGY (2011)
Circumferential resection margin as a prognostic factor in rectal cancer
T. E. Bernstein et al.
BRITISH JOURNAL OF SURGERY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Locally Advanced Rectal Cancer: Added Value of Diffusion-weighted MR Imaging in the Evaluation of Tumor Response to Neoadjuvant Chemo- and Radiation Therapy
Seung Ho Kim et al.
RADIOLOGY (2009)
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
Morten Braendengen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer
Sang Min Yoon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy
FM Smith et al.
EJSO (2006)
Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
R Ryan et al.
HISTOPATHOLOGY (2005)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)